期刊文献+

盐酸多奈哌齐对正常成年大鼠学习和记忆功能的影响 被引量:1

Effect of donepezil hydrochloride on learning and memory function in normal adult rats
下载PDF
导出
摘要 目的:探讨盐酸多奈哌齐(DPH)对正常成年大鼠学习、记忆功能的影响。方法:采用区组随机分组方法按体重随机将Wistar大鼠分为正常对照组及DPH(n=20),DPH组灌胃给DPH 0.85 mg·kg^-1·d^-1,正常对照组灌胃同体积的生理盐水,连续给药10 d后,采用Morris水迷宫、跳台行为学实验方法,观察DPH对正常成年大鼠学习、记忆功能的影响。结果:DPH大鼠给药第1-6天达到平台的潜伏期、游程、平均速度、朝向角及第7天大鼠在2 min内的穿越平台的次数、在平台区的逗留时间、平台象限内的逗留时间、平均速度、朝向角及平台区象限内的游程占总游程的百分比,与正常对照组比较差异均无显著性(P〉0.05);DPH组大鼠第1和2天跳台的错误次数及潜伏期,与正常对照组比较差异均无显著性(P〉0.05)。结论:DPH对正常成年大鼠学习、记忆功能无促进作用。 Objective To explore the effects of donepezil hydrochloride on learning and memory function in normal adult rats. Methods According to weight, 40 Wistar rats were randomly divided into 2 groups: normal control group and donepezil hydrochloride group (n= 20). The learning and memory function in rats were determined with Morris water maze and Step-down tests. Results Compared with control group, latency, distance, average speed and starting angle of rats treated by donepezil hydrochloride did not change significantly from the first day to the sixth day (P〉0.05) ; the time in platform, the time of platform quadrant in 2 minutes, times passing platform, the percentage of distance in platform / total distance and average speed also did not change significantly on the 7th day in Morris water maze test (P〉0.05) ; Error times of rats treated by donepezil hydrochloride did not decrease on the 1st and 2nd day (P〉0.05), latency did not prolong in the 2nd day in Step-down test (P〉0.05) Conclusion Donepezil hydrochloride do not improve learning and memory function in normal adult rats.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2007年第3期467-469,共3页 Journal of Jilin University:Medicine Edition
基金 吉林省科技厅资助课题(20030551-1)
关键词 盐酸多奈哌齐 学习 记忆 大鼠 Wistar Donepezil hydrochloride learning memory rats, Wistar
  • 相关文献

参考文献7

二级参考文献16

  • 1Pulsinelli W A, Brierley J B. A new model of bilateral hemispheric ischemia in the unanaesthetized rat[J]. Stroke, 1979, 10(3): 267 - 272.
  • 2Reinikainen K J, Riekkinen P J, Jokkonen J, et al. Decreased somatostatin-like im munoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease[J]. Brain Res, 1987, 402(1): 103- 108.
  • 3Nilsson L, Mohammed A K, Henriksson B G, et al. Influence of place learning on somatostatin levels in the rat brain following environmental deprivation[J]. Regul Pept, 1995, 58(1-2): 11-18.
  • 4Van Uden E, Veinbergs I, Mallory M, et al. A novel role for receptor-associated protein in somatostatin modulation: implications for Alzheimer' s disease[J]. Neuroscience, 1999, 88(3): 687-700.
  • 5Grouselle D, Winsky-Sommerer R, David J P, et al. Loss of somatostatinlike immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele[J]. Neurosci Lett, 1998, 255( 1 ): 21 - 24.
  • 6Corey-Bloom J, Tiraboschi P, Hansen L A, et al. FA allele dosage does not predict cholinergic activity or synapse loss in Alzheimer' s disease[J].Neurology, 2000, 54(2): 403- 406.
  • 7Yamazaki M, Matsuoka N, Maeda N, et al. FK960 N-(4-acetyl-l-piperaziny)- P-fluorobenzamide monohydrate ameliorates the memory dodicits in rats through a novel mechanism of action[J]. J Pharmaco Exp Ther, 1996,279(3): 1157- 1173.
  • 8Ishida N, Akaike M, Tsutsumi S, et al. Trimethyltin syndrome as a hippocampal degeneration model: temporal changes and neurochemical features of seizure susceptibility and learning impairment[J]. Neuroscience, 1997,81(4): 1183- 1191.
  • 9Tatemici TK, Desmond DW, Mayeux R,et al. Dementia after stroke:baseline frequency, risk, and clinical features in a hospitalized cohort[J]. Neurology, 1992,42:1185-1193.
  • 10Erkinjuntli T, Hachinski VC. Rethinking vascular dementia[J]. Cerebrovasc Dis, 1993,3:3-23.

共引文献53

同被引文献7

  • 1Passmore AP, Bayer AJ, Steinhagen TE. Cognitive, global, and functional benefit of donepezil in Alzheimer, s disease and vascular dementia: results from large-scale clinical trisls [J]. NeurolSei, 2005, 229 230: 141-146.
  • 2Raymond DP. Ratient populations in clinical trials of the efficacy and tolerability of donepezil in patients with vascular dementia[J]. NeurolSci, 2002, 203-204:57 -65.
  • 3Erkinjuntti T, Roman G, Gauthier S. Treatment of vascular dementia- evidence from clinical trials with cholinesterase inhibitors. Neurological[J]. Sciences, 2004, 26 (5): 603- 605.
  • 4Skoog I, Kataria RN, Breteler MM. Vascular factors and Alzheimer disease [J]. Alzheimer Dis Assoc Disord, 1999, 13 (suppl3): S106.
  • 5李定国,张中红,张明,尚敏,张新洲,郑君杰,郑永毅,郭晋武.多奈哌齐与他克林治疗阿尔茨海默病的对照研究[J].中华精神科杂志,2002,35(4):216-219. 被引量:7
  • 6丁素菊,吴帅,崔毅,张永巍,毕晓莹.盐酸多奈哌齐治疗血管性痴呆的有效性和安全性[J].中华老年心脑血管病杂志,2003,5(6):395-396. 被引量:17
  • 7张莉莉,王景周,刘文生,陈曼娥.血管性痴呆大鼠脑中生长抑素和乙酰胆碱含量的变化[J].第三军医大学学报,2004,26(8):714-716. 被引量:17

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部